Staff at the US Federal Trade Commission said it appears Novo Nordisk A/S’ proposed bid for Metsera Inc. “may violate the ...

Novo Nordisk A/S downgraded after Q3 earnings and weight loss sector risks. Explore valuation, partnerships, and market ...

Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...

Novo Nordisk (NVO) posts new late-stage trial data to highlight blood sugar control and cardiovascular benefits associated with its Wegovy in a pill. Read more here.

Pfizer is increasing its offer for Metsera. This comes after a judge rejected Pfizer's attempt to stop rival Novo Nordisk's ...

Novo Nordisk A/S NVO reported third-quarter 2025 earnings of 70 cents per American Depositary Receipt (ADR), which missed the ...

Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on percentage weight loss onlyBody mass index (BMI) and waist-to-height ratio (a ...

The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...

HIGHLIGHTS Rock chip results from a recently completed reconnaissance program at the Tibooburra Gold Project defined new ...

Novo Nordisk said the overhaul resulted in one-off costs of about DKK 9 billion in 2025, including DKK 5 billion in severance ...